Dementia Related Content

Fiona Carragher, Director of Research and Influencing at Alzheimer’s Society walks us through why a reformed social care system in the UK cannot wait.

Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.

Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.

Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, China charts how to deal with dementia during the COVID-19 pandemic, starting with a helpful global and regional overview.

New research by the University of East Anglia found that 70% of people with dementia go missing - but why? 

A new 'white matter lesion' mapping tool can find early signs of dementia, with more than 70% accuracy in measuring mental decline.

Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.

Researchers from Boston University, have found that incidents of racial discrimination are associated with lower subjective cognitive function (SCF) among African-American women.

Here, Dr Deborah Lee, Dr Fox Online Pharmacy, explores the link between diabetes and the increased risk of developing dementia.

Therese Pei Fong Chow Research Centre for Prevention of Dementia, the Chinese University of Hong Kong, discuss if B vitamins can improve cognitive function in older people.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shines the spotlight on dementia in the digital era, from a Hong Kong perspective.

Researchers at the University of Exeter Medical School and the University of Connecticut School of Medicine found that a faulty gene linked to dementia doubles the risk of developing severe COVID-19.

In this North America April 2020 edition, David Goff at the National Heart, Lung, and Blood Institute, details the support for heart and vascular health research.

Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.

Here, the Department of Medicine & Therapeutics discuss the programmes that are supporting post-hospital care for Dementia patients.

Rachel Conant, Vice President Federal Affairs, Alzheimer’s Association and Alzheimer’s Impact Movement, provides us with an update on Alzheimer’s and dementia funding rises in the United States.

Here, Dr Masanori Katakura from the Laboratory of Nutritional Physiology, explains the importance of keeping the kidneys healthy, as well as the surprisingly common condition, chronic kidney disease (CKD).

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.

Ella Hendrix, Writer, takes it back to basics and explains the difference between Dementia and Alzheimer's disease